Thomas Hutson - Baylor Health Care System

基本信息

浏览量：0

职业迁徙

个人简介

GU/Uroloigc Medical Oncologist engaged in clinical research to improve outcomes for patients with Kidney Cancer, Bladder Cancer, Prostate Cancer and Testicular Cancer.

研究兴趣

论文共 390 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

A Phase 1/1b First-in-human (FIH) Study of JZP898 As Monotherapy and in Combination with Pembrolizumab in Adult Patients with Advanced or Metastatic Solid Tumors

Meredith McKean,Thomas E. Hutson,Sarina A. Piha-Paul,Ida Micaily, Mingxiang Liao,Robin Humphreys,Graham Brock,Natasha Sahr,Vian Amber, Alexander I. Spira

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

A Multicenter, Open-Label, Phase 1a Study of HC-5404 in Patients with Advanced Solid Tumors

Arkadiusz Z. Dudek,Joyce O'Shaughnessy,Sarina A. Piha-Paul,Dipesh Uprety, Benjamin Lee Kitchens,Thomas E. Hutson, Brian H. Rank,Michael Stokes,Crissy Dudgeon,David Surguladze,Eric Lightcap,Jeremy Drees,Ben Harrison, Richard Li,Ashley LaCayo,Paulette Mattson,Nandita Bose, Dhamina Karim,Michele Anne Gargano,Jose Luis Iglesias

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Lenvatinib Plus Pembrolizumab (L+P) Vs Sunitinib (S) in Advanced Renal Cell Carcinoma (arcc): Patterns of Progression and Subsequent Therapy in the CLEAR Trial

Viktor Grunwald,Robert J. Motzer,Daniel Keizman,Jens Bedke,Manuela Schmidinger,Michael D. Staehler,Vsevolod B. Matveev,Saby George,Thomas E. Hutson,Ulka N. Vaishampayan,Jaime R. Merchan,Masatoshi Eto,Sun Young Rha,Tom Waddell,Roberto Sabbatini,Philippe Barthelemy,Joseph E. Burgents,Min Ren, Ian Brown,Toni K. Choueiri

Journal of Clinical Oncologyno. 16_suppl (2024): 4524-4524

引用0浏览0引用

Long-Term Survival in Patients with Relapsed/Refractory Advanced Renal Cell Carcinoma Treated with Tivozanib: Analysis of the Phase III TIVO-3 Trial

Kathryn E. Beckermann,Aviva G. Asnis-Alibozek,Michael B. Atkins,Bernard Escudier,Thomas E. Hutson,Vijay Kasturi,David F. Mcdermott,Sumanta K. Pal,Camillo Porta,Brian Rini,Elena Verzoni

ONCOLOGISTno. 3 (2024): 254-262

引用0浏览0WOS引用

A Phase 1b, Open-Label, Safety, Tolerability, and Efficacy Study of HC-7366 in Combination with Belzutifan (WELIREG™) in Patients with Advanced or Metastatic Renal Cell Carcinoma, NCT06234605

Rana R. McKay, Ben Garmezy,Pedro Barata,Moshe Ornstein,Neil J. Shah,Hans Hammers,Thomas E. Hutson,Michael Chisamore, Dhamina Karim,Paulette Mattson,Eric Lightcap,Jeremy Drees,Ben Harrison, Megan Holm,Nandita Bose, Cherry T. Thomas,Robert J. Motzer

ONCOLOGIST (2024): S13-S13

引用0浏览0引用

Phase 2 Trial for Sequential Treatment of High Dose Cabozantinib (CABO) or CABO Plus Nivolumab (NIVO) On/after Progression on CABO Monotherapy in Advanced Renal Cell Carcinoma (RCC): Seq-Cabo

Qian Qin,James Brugarolas, Hans J. Hammers,Waddah Arafat,Kevin Dale Courtney, Jue Wang,Changchuan Jiang, Song Zhang,Charles Lance Cowey,Thomas E. Hutson,Tian Zhang

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn